Skip to main content
Premium Trial:

Request an Annual Quote

PerkinElmer, Beckman Coulter

PerkinElmer last week launched its Constitutional Chip 4.0 microarray for array-based comparative genomic hybridization.
The new tool is a bacterial artificial chromosome array intended for identification of chromosomal gain or loss of DNA and identification of the region in which gain or loss has occurred. Specifically, the chip contains more than 5,000 BAC clones covering 25 percent of the human genome; 90 well-characterized chromosomal regions covered by more than 1,200 BAC clones; improved subtelomere coverage; and high-resolution detection of chromosomal gains and losses across the X chromosome.
The Constitutional Chip 4.0 is designed to be used with PE’s aCGH reagents, ScanArray scanners and image processing software, and SpectralWare aCGH analysis software.

Beckman Coulter last week launched the Agencourt DNAdvance System, a new extraction kit for DNA isolation and purification from mammalian tissue samples. 
The system incorporates Beckman’s Solid Phase Reversible Immobilization paramagnetic bead-based, nucleic acid purification technology. The Agencourt DNAdvance chemistry is also automated on the Beckman Coulter Biomek NXP and FXP Laboratory Automation Workstations.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.